This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Integral Molecular, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Innovations of Kyle Doolan in Antibody Development
Introduction
Kyle Doolan is an accomplished inventor based in Philadelphia, PA. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. Her work focuses on innovative solutions that address critical medical challenges.
Latest Patents
Kyle Doolan holds a patent for "Antibodies directed to claudin 6, including bispecific formats thereof." This patent discloses an antibody specific for claudin 6 and CD3, along with methods for preparing and utilizing these antibodies. The patent details the isolation and characterization of antibodies, antibody fragments, and antibody variants that are specific for claudin 6 and CD3. This innovation has the potential to impact therapeutic approaches in various medical applications.
Career Highlights
Kyle Doolan is currently employed at Integral Molecular, Inc., where she continues to advance her research in antibody development. Her expertise and dedication to her work have positioned her as a key figure in her field.
Collaborations
Kyle collaborates with her coworker, Joseph B Rucker, to further enhance their research efforts and drive innovation in antibody technology.
Conclusion
Kyle Doolan's contributions to the field of biotechnology, particularly through her patent on antibodies, showcase her innovative spirit and commitment to advancing medical science. Her work at Integral Molecular, Inc. continues to pave the way for future breakthroughs in antibody therapies.